Effects of Aerobic Training on Cerebrovascular Function, Cognitive Performance and Gait Parameters in Patients With Parkinson's Disease: A Randomized Controlled Trial
This randomized controlled trial will investigate the effects of a 12-week supervised aerobic training program on cerebrovascular function, peripheral vascular health, cardiovascular autonomic modulation, cognition, non-motor symptoms, sleep, mood, gait biomechanics, quality of life, and body composition in patients with Parkinson's disease (Hoehn \& Yahr stages 1-3). Participants will be randomly allocated to aerobic training or usual care.
• Clinical diagnosis of Parkinson's disease
• Hoehn \& Yahr stages 1-3
• Stable antiparkinsonian medication for at least 4 weeks
• Montreal Cognitive Assessment (MoCA) score ≥ 18
• Ability to walk independently (with or without assistive device)
• Medical clearance for participation in moderate-intensity exercise